Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Research Alliance with Bayer

Bayer AG is a multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. It has core competencies in the life science fields of health care and nutrition and one of the Top 20 pharmaceutical companies world-wide.  Bayer specialises in prescription products for oncology, cardiology, eye diseases and women’s healthcare.

Bayer logo

About the Oxford-Bayer Alliance

The University of Oxford collaborates with Bayer on a number of projects focused around Women’s Health. The alliance has the specific aim of identifying and characterising novel drug targets for women’s unmet health needs in endometriosis, uterine fibroids and polycystic ovarian syndrome (PCOS). The pathways and mechanisms underlying these conditions remain poorly understood. A comprehensive programme to dissect the disease-causing processes is being undertaken. An immense benefit to the alliance is the availability of scarce samples through the Oxford University Hospital Trust.

Therapeutic areas of interest

  • Women's health
  • Endometriosis
  • Uterine fibroids
  • Polycystic Ovarian Syndrome (PCOS)

    alliance activities

    • Co-applicants on a grant
    • Consulting
    • Sponsored research collaborations

    Alliance Manager